To Study the Characteristics of Different Types of Vertigo in Patients Attending the Ear Nose & Throat (ENT) Clinics.
VERTIGO
1 other identifier
observational
400
1 country
11
Brief Summary
The VERTIGO study is likely to help determine characteristics of different types of vertigo in patients presenting in the Ear Nose \& Throat (ENT) clinics with complaints of dizziness. Moreover, it will also help to develop an understanding about the current management practices of this condition at local level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2014
Shorter than P25 for all trials
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 8, 2014
CompletedFirst Posted
Study publicly available on registry
August 11, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedMay 28, 2015
May 1, 2015
6 months
August 8, 2014
May 27, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Characteristics (Different Types) of dizziness
It will be determined that a patient with dizziness is suffering from what type of Vertigo i.e. Benign Paroxysmal Positional Vertigo, Menier's Disease, Vestibular Neuritis, Labyrinthitis or any other. As these are clinical types of Vertigo these cannot be measured in units
6 months
Secondary Outcomes (3)
Quality of Life (QoL) of patients at baselines
6 months
Management of vertigo currently in practice
6 months
QoL of patients post treatment
6 months
Study Arms (1)
Dizziness
Patients with Dizziness
Eligibility Criteria
Primary Care Clinic/Private Clinic
You may qualify if:
- Male or female patients 18 years of age and older
- Patients with vestibular vertigo of known or unknown origin
- Patients who are willing and able to provide written informed consent
You may not qualify if:
- Patient with psychiatric disorders, significant neurological disorder or spinal cord damage that would make the evaluation difficult for the investigator
- Patients who are not willing to give informed consent
- Patients with a known history of hypersensitivity to betahistine
- Patients with a history of pheochromocytoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Abbottlead
- Dimension Researchcollaborator
Study Sites (11)
Research facility ID ORG-001139
Hyderābād, 76090, Pakistan
Research facility ID ORG-001053
Islamabad, 44000, Pakistan
Research facility ID ORG-001070
Karachi, 75050, Pakistan
Research facility ID ORG-001051
Karachi, 75190, Pakistan
Research facility ID ORG-001069
Karachi, 75900, Pakistan
Research facility ID ORG-001050
Karachi, 75950, Pakistan
Research facility ID ORG-001060
Lahore, 54570, Pakistan
Research facility ID ORG-001054
Lahore, 54660, Pakistan
Research facility ID ORG-001055
Lahore, 54660, Pakistan
Research facility ID ORG-001061
Lahore, 54810, Pakistan
Research facility ID ORG-001052
Peshawar, 7041298, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Raeefuddin Ahmed, MD
Abbott
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 8, 2014
First Posted
August 11, 2014
Study Start
August 1, 2014
Primary Completion
February 1, 2015
Study Completion
March 1, 2015
Last Updated
May 28, 2015
Record last verified: 2015-05